Answers are grounded in this paper and cite their sources.
Contemporary reviews on the pathogenesis of inflammatory bowel diseases (IBDs; most commonly Crohn’s disease [CD] and ulcerative colitis [UC]) consistently invoke the etiologic triad of genetics, the environment, and the immune system (Figure 1).1–3 Yet the current treatment paradigm for IBDs exclusively seeks to dampen or modulate what is presumed to be an excessive or aberrant immune response. Despite mounting recognition that environmental factors (microbes, diet, and other exposures associated with a Western lifestyle) are critical contributors to both the etiology and the maintenance of disease,4,5 current guideline-based therapies are primarily immunomodulatory.
No takes yet. Share an insight, caveat, or question.
Behr et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: